| 1GKO | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| related structures | by homologous chain: 1SOQ, 2TRY | ||||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured., Jiang X, Smith CS, Petrassi HM, Hammarstrom P, White JT, Sacchettini JC, Kelly JW, Biochemistry 2001 Sep 25;40(38):11442-52. PMID:11560492 | ||||||||||||||
| Data retrieval |
![]() |
| View 1GKO in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |